Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma

PURPOSE: To evaluate the pharmacokinetic properties of UGN-101, a mitomycin-containing reverse thermal gel used as primary chemoablative treatment for low-grade upper tract urothelial carcinoma (UTUC), in a subset of patients participating in a phase 3 clinical trial. METHODS: Pharmacokinetic parame...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabsigh, Ahmad, Kleinmann, Nir, Smith, Angela B., Scherr, Douglas, Seltzer, Elyse, Schoenberg, Mark, Lerner, Seth P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110485/
https://www.ncbi.nlm.nih.gov/pubmed/33677615
http://dx.doi.org/10.1007/s00280-021-04246-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110485/
https://www.ncbi.nlm.nih.gov/pubmed/33677615
http://dx.doi.org/10.1007/s00280-021-04246-w

Ejemplares similares